COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics Announces Evolution in Company’s Board of Directors and Management
12/04/2018
Dominique Costantini, MD, Appointed as Chairman of Company’s Board of Directors, Alexis Peyroles Appointed as Chief Executive Officer Natural, Seamless Evolution Follows Three Structuring License Agreements to Drive [...]
Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at EASL 2018
12/04/2018
Capsid inhibitor with HBV RNA Destabilizer Demonstrate Complementary Efficacy Results Subcutaneous RNAi Agent Demonstrates Durable HBsAg Reduction Following a Single Dose VANCOUVER, British Columbia and WARMINSTER, Pa [...]
Virbac : 2018 first quarter revenue rose by +3.3% at comparable exchange rates
12/04/2018
2018 first quarter revenue rose by +3.3% at comparable exchange rates Public release dated April 12, 2018 Key figures Net revenue 1 st quarter 2018 193.5 m€ Total growth -3.1% Growth at constant exchange rates +3.3% [...]
Virbac : Chiffre d'affaires du premier trimestre 2018 en progression de +3,3% à taux de change comparables
12/04/2018
Chiffre d'affaires du premier trimestre 2018 en progression de +3,3% à taux de change comparables Communiqué diffusé le 12 avril 2018 Chiffres clÉs Chiffre d'affaires 1 er trimestre 2018 193,5 M€ Évolution globale -3,1 [...]
Nicox : Assemblées Générales Ordinaire et Extraordinaire 2018
12/04/2018
Nicox : Assemblées Générales Ordinaire et Extraordinaire 2018 ............................................. 12 avril 2018 Sophia Antipolis, France Nicox SA (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société [...]
Clinical Cancer Research Publishes Phase I Data from a Study of Rafael Pharmaceuticals' Lead CPI-613 Compound in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
12/04/2018
Newark, NJ, April 12, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that data from the Phase I clinical trial evaluating [...]
Terveystalo Plc: Resolutions of Annual General Meeting
12/04/2018
Terveystalo Plc, Stock Exchange Release 12 April 2018 at 17:35 EET The Annual General Meeting of Terveystalo Plc was held today on 12 April 2018 in Helsinki, Finland. The Annual General Meeting adopted the financial [...]
Medifirst Solutions Announces the Launch of a New Division Focusing on Specialty Prescription Billing and Pharmacy Solutions
12/04/2018
FREEHOLD, NJ, April 12, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]
C-RAD Web Presentation Interim Report Q1 2018
12/04/2018
Presentation of the report for the first quarter of the fiscal year 2018: Date: Thursday April 26, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Interim Report Q1 2018 Procedure: Please register online [...]
Matrix Medical Network announces the appointment of Heidi Cannon as Senior Vice President, Account Management
12/04/2018
SCOTTSDALE, Ariz., April 12, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix), a leading population health provider of in-home and mobile health services, has announced that Heidi Cannon has joined the company [...]
Nymox Announces $16.25 Million Equity Financing With Qualified Long-Term Investors
12/04/2018
HASBROUCK HEIGHTS, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to announce today that the Company has successfully secured $16.25 million in new equity capital [...]
ICC Labs Enters Into Term Sheet for Export of Cannabidiol to Sundial in Canada
12/04/2018
Highlights: Term sheet paves the way for the distribution of ICC Labs’ medicinal cannabidiol (CBD) products through Sundial’s licensed dealer partners in Canada Sundial to purchase up to 250,000 grams per year of pure [...]
Reduction of common stock
12/04/2018
Please read the full announcement in the attached PDF Attachment 2018_13_Reduction_of_common_stock_EN
Fluidigm Releases CFTR Next-Generation Sequencing Library Prep Assay for Use With the Juno System
12/04/2018
SOUTH SAN FRANCISCO, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced the introduction of the Advanta™ CFTR NGS Library Prep Assay, a highly efficient and scalable next- [...]
PolarityTE Announces Pricing of Public Offering of Common Stock
12/04/2018
SALT LAKE CITY, April 12, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]
Hitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution Rights
12/04/2018
BUFFALO, N.Y., April 12, 2018 (GLOBE NEWSWIRE) -- OmniSeq ® , a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, announced today Hitachi High-Technologies Corporation (TYO:8036) (Hitachi [...]
Press Release: Chief Executive Officer Yrjö Närhinen to Terveystalo's Annual General Meeting of Shareholders 2018: It is now time to develop the Finnish healthcare system further
12/04/2018
In his address to the Annual General Meeting of Shareholders, Chief Executive Officer Yrjö Närhinen highlighted the ever-important role of private healthcare services in the Finnish society and healthcare system. Now it [...]
Targovax strengthens Board of Directors with the appointment of Catherine Wheeler
12/04/2018
Oslo, Norway, 12 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces the appointment of Catherine Wheeler MD to the [...]
Imagin Medical Closing Private Placement
12/04/2018
VANCOUVER, British Columbia, April 12, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt: DPD2 ) (STUT:DPD2) (the “Company”) announced today that, further to its press release of April 3, [...]

Pages